Impact of Locoregional Treatment of Soft Tissue Sarcoma on Status of Patients Aged 70 Years and Over (SARCOLD)
Evaluation of the Impact of Locoregional Treatment of Soft Tissue Sarcoma on the Functional Status of Patients Aged 70 Years and Over
Sponsor: Institut Bergonié
This NA trial investigates Soft Tissue Sarcoma Adult and is currently ongoing. Institut Bergonié leads this study, which shows 10 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
10 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting NA
-
Nov 2025 — Feb 2026 [monthly]
Active Not Recruiting NA
-
Dec 2024 — Nov 2025 [monthly]
Active Not Recruiting NA
Status: Unknown → Active Not Recruiting
-
Sep 2024 — Dec 2024 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
▶ Show 5 earlier versions
-
Apr 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Apr 2023 [monthly]
Recruiting NA
-
Jun 2018 — Jan 2021 [monthly]
Recruiting NA
-
Dec 2017 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Apr 2017 — Dec 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Institut Bergonié
- Ministry of Health, France
For direct contact, visit the study record on ClinicalTrials.gov .